SEC
|
DIAZ PAUL J
|
President and CEO
|
|
-15K
|
$22.93
|
-$343.95K
|
|
SEC
|
DIAZ PAUL J
|
President and CEO
|
|
-15K
|
$26.72
|
-$400.80K
|
|
SEC
|
Muzzey Dale
|
Chief Scientific Officer
|
|
-2.1K
|
$26.17
|
-$54.96K
|
|
SEC
|
Dreismann Heinrich
|
N/A
|
|
-10K
|
$27.05
|
-$270.50K
|
|
SEC
|
Reitan Colleen F
|
N/A
|
|
-46K
|
$27.95
|
-$1.29M
|
|
SEC
|
Ancona Margaret
|
SVP, Chief of Staff
|
|
-12K
|
$27.82
|
-$320.99K
|
|
SEC
|
Kumar Rashmi
|
N/A
|
|
-7.5K
|
$28.01
|
-$210.08K
|
|
SEC
|
SPIEGELMAN DANIEL K
|
N/A
|
|
-7.6K
|
$22.05
|
-$167.05K
|
|
SEC
|
DIAZ PAUL J
|
President and CEO
|
|
-228K
|
$25.14
|
-$5.73M
|
|
SEC
|
Newcomer Lee Nisley
|
N/A
|
|
-6.2K
|
$25.30
|
-$156.86K
|
|
SEC
|
Riggsbee Richard Bryan
|
Chief Financial Officer
|
|
-30K
|
$19.09
|
-$572.70K
|
|
SEC
|
Riggsbee Richard Bryan
|
Chief Financial Officer
|
|
-30K
|
$15.69
|
-$470.70K
|
|
SEC
|
SPIEGELMAN DANIEL K
|
N/A
|
|
-8.6K
|
$23.01
|
-$198.76K
|
|
SEC
|
Lambert Nicole
|
Chief Operating Officer
|
|
-6.4K
|
$23.48
|
-$151.05K
|
|
SEC
|
Lambert Nicole
|
Chief Operating Officer
|
|
-13K
|
$22.74
|
-$299.80K
|
|
SEC
|
Riggsbee Richard Bryan
|
Chief Financial Officer
|
|
-15K
|
$22.55
|
-$338.25K
|
|
SEC
|
Riggsbee Richard Bryan
|
Chief Financial Officer
|
|
-9.4K
|
$20.04
|
-$188.38K
|
|
SEC
|
Riggsbee Richard Bryan
|
Chief Financial Officer
|
|
-600
|
$20.01
|
-$12.01K
|
|
SEC
|
Lambert Nicole
|
Chief Operating Officer
|
|
-853
|
$14.51
|
-$12.38K
|
|
SEC
|
Muzzey Dale
|
Chief Scientific Officer
|
|
-302
|
$14.51
|
-$4.38K
|
|
SEC
|
Riggsbee Richard Bryan
|
Chief Financial Officer
|
|
-20K
|
$15.15
|
-$303.00K
|
|
SEC
|
Wong Pamela
|
Chief Legal Officer
|
|
-3.3K
|
$20.00
|
-$66.36K
|
|
SEC
|
Haas Kevin Richard
|
Chief Technology Officer
|
|
-1.7K
|
$19.62
|
-$33.77K
|
|
SEC
|
Hart Jayne B.
|
Chief People Officer
|
|
-4.9K
|
$19.62
|
-$96.65K
|
|
SEC
|
Lambert Nicole
|
Chief Operating Officer
|
|
-12K
|
$19.62
|
-$237.76K
|
|
SEC
|
Muzzey Dale
|
Chief Scientific Officer
|
|
-309
|
$19.62
|
-$6.06K
|
|
SEC
|
Riggsbee Richard Bryan
|
Chief Financial Officer
|
|
-12K
|
$19.62
|
-$242.99K
|
|
SEC
|
Verratti Mark
|
Chief Commercial Officer
|
|
-8.4K
|
$19.62
|
-$164.14K
|
|
SEC
|
Haas Kevin Richard
|
Chief Technology Officer
|
|
-1.2K
|
$18.49
|
-$22.34K
|
|
SEC
|
Hart Jayne B.
|
Chief People Officer
|
|
-3.9K
|
$18.53
|
-$71.86K
|
|
SEC
|
Lambert Nicole
|
Chief Operating Officer
|
|
-3.6K
|
$18.46
|
-$66.31K
|
|
SEC
|
Muzzey Dale
|
Chief Scientific Officer
|
|
-478
|
$18.61
|
-$8.90K
|
|
SEC
|
Riggsbee Richard Bryan
|
Chief Financial Officer
|
|
-9.8K
|
$18.56
|
-$182.00K
|
|
SEC
|
Verratti Mark
|
Chief Commercial Officer
|
|
-5.1K
|
$18.56
|
-$94.40K
|
|
SEC
|
Verratti Mark
|
Chief Commercial Officer
|
|
-702
|
$20.20
|
-$14.18K
|
|
SEC
|
Hart Jayne B.
|
Chief People Officer
|
|
+1K
|
$14.84
|
+$15.37K
|
|
SEC
|
SPIEGELMAN DANIEL K
|
N/A
|
|
-6.4K
|
$19.25
|
-$123.66K
|
|
SEC
|
Santa Eric
|
Chief Growth Officer
|
|
-3K
|
$25.88
|
-$77.02K
|
|
SEC
|
DIAZ PAUL J
|
President and CEO
|
|
-44K
|
$25.32
|
-$1.12M
|
|
SEC
|
Hart Jayne B.
|
Chief People Officer
|
|
-3.6K
|
$25.32
|
-$92.19K
|
|
SEC
|
Verratti Mark
|
President, Mental Health
|
|
-2.7K
|
$25.32
|
-$67.50K
|
|
SEC
|
Hart Jayne B.
|
Chief People Officer
|
|
-11K
|
$25.00
|
-$262.50K
|
|
SEC
|
Riggsbee Richard Bryan
|
Chief Financial Officer
|
|
+37K
|
$4.85
|
+$178.62K
|
|
SEC
|
Hart Jayne B.
|
Chief People Officer
|
|
+143
|
$21.98
|
+$3.14K
|
|
SEC
|
Haas Kevin Richard
|
Chief Technology Officer
|
|
-1.7K
|
$30.88
|
-$53.39K
|
|
SEC
|
Hart Jayne B.
|
Chief People Officer
|
|
-4.9K
|
$30.88
|
-$152.11K
|
|
SEC
|
Lambert Nicole
|
See Remarks
|
|
-12K
|
$30.88
|
-$385.48K
|
|
SEC
|
LANCHBURY JERRY S
|
Chief Scientific Officer
|
|
-11K
|
$30.88
|
-$333.84K
|
|
SEC
|
Riggsbee Richard Bryan
|
Chief Financial Officer
|
|
-12K
|
$30.88
|
-$382.85K
|
|
SEC
|
Verratti Mark
|
President, Myriad Neuroscience
|
|
-8.3K
|
$30.88
|
-$257.54K
|
|
SEC
|
Lambert Nicole
|
See Remarks
|
|
-1.4K
|
$31.57
|
-$44.83K
|
|
SEC
|
Lambert Nicole
|
See Remarks
|
|
-15K
|
$33.17
|
-$492.54K
|
|
SEC
|
Haas Kevin Richard
|
Chief Technology Officer
|
|
-1.2K
|
$33.31
|
-$40.34K
|
|
SEC
|
Hart Jayne B.
|
Chief People Officer
|
|
-6.1K
|
$33.31
|
-$202.99K
|
|
SEC
|
LANCHBURY JERRY S
|
Chief Scientific Officer
|
|
-14K
|
$33.34
|
-$452.76K
|
|
SEC
|
Riggsbee Richard Bryan
|
Chief Financial Officer
|
|
-16K
|
$33.31
|
-$547.88K
|
|
SEC
|
Verratti Mark
|
President, Myriad Neuroscience
|
|
-10K
|
$33.31
|
-$341.76K
|
|
SEC
|
DIAZ PAUL J
|
President and CEO
|
|
+396K
|
$3.47
|
+$1.37M
|
|
SEC
|
Hart Jayne B.
|
Chief People Officer
|
|
+9.6K
|
$29.87
|
+$285.38K
|
|
SEC
|
Hart Jayne B.
|
Chief People Officer
|
|
-1.1K
|
$34.81
|
-$39.96K
|
|
SEC
|
Lambert Nicole
|
See Remarks
|
|
-1.1K
|
$34.81
|
-$39.09K
|
|
SEC
|
LANCHBURY JERRY S
|
Chief Scientific Officer
|
|
-2.2K
|
$34.81
|
-$77.73K
|
|
SEC
|
Riggsbee Richard Bryan
|
Chief Financial Officer
|
|
-6.3K
|
$16.88
|
-$106.48K
|
|
SEC
|
Verratti Mark
|
President, Myriad Neuroscience
|
|
-1.1K
|
$34.81
|
-$37.66K
|
|
SEC
|
Phanstiel S. Louise
|
N/A
|
|
+12K
|
$28.53
|
+$345.76K
|
|
SEC
|
Riggsbee Richard Bryan
|
Chief Financial Officer
|
|
-15K
|
$35.14
|
-$526.50K
|
|
SEC
|
LANCHBURY JERRY S
|
Chief Scientific Officer
|
|
-93K
|
$33.64
|
-$3.14M
|
|
SEC
|
LANCHBURY JERRY S
|
Chief Scientific Officer
|
|
-33K
|
$27.27
|
-$910.05K
|
|
SEC
|
SPIEGELMAN DANIEL K
|
N/A
|
|
-3.1K
|
$30.52
|
-$95.80K
|
|
SEC
|
Haas Kevin Richard
|
Chief Technology Officer
|
|
+344
|
$15.86
|
+$5.46K
|
|
SEC
|
Hart Jayne B.
|
Chief People Officer
|
|
+1.1K
|
$15.86
|
+$17.16K
|
|
SEC
|
SPIEGELMAN DANIEL K
|
N/A
|
|
-7.1K
|
$28.99
|
-$207.05K
|
|
SEC
|
LANCHBURY JERRY S
|
Chief Scientific Officer
|
|
-40K
|
$31.47
|
-$1.26M
|
|
SEC
|
Lambert Nicole
|
See Remarks
|
|
-6.6K
|
$27.01
|
-$179.59K
|
|
SEC
|
Hart Jayne B.
|
Chief People Officer
|
|
-58K
|
$30.00
|
-$1.74M
|
|
SEC
|
Parkinson Paul
|
EVP Strategy and Innovation
|
|
-12K
|
$25.00
|
-$295.60K
|
|
SEC
|
Phanstiel S. Louise
|
N/A
|
|
+15K
|
$16.62
|
+$249.30K
|
|
SEC
|
Parkinson Paul
|
EVP Strategy and Innovation
|
|
-2.2K
|
$12.43
|
-$27.57K
|
|
SEC
|
Ford Alexander
|
Chief Operating Officer
|
|
-6.7K
|
$13.04
|
-$86.76K
|
|
SEC
|
Hart Jayne B.
|
Executive VP Human Resources
|
|
-2.2K
|
$13.04
|
-$28.92K
|
|
SEC
|
Jackson Benjamin
|
E.V.P., General Counsel
|
|
-416
|
$13.04
|
-$5.42K
|
|
SEC
|
Lambert Nicole
|
President, MGL
|
|
-591
|
$13.04
|
-$7.71K
|
|
SEC
|
LANCHBURY JERRY S
|
Chief Scientific Officer
|
|
-5.5K
|
$13.04
|
-$72.29K
|
|
SEC
|
Riggsbee Richard Bryan
|
Chief Financial Officer
|
|
-6.7K
|
$13.04
|
-$86.76K
|
|
SEC
|
Verratti Mark
|
President Assurex Health Inc.
|
|
-725
|
$13.04
|
-$9.45K
|
|
SEC
|
Ford Alexander
|
Chief Operating Officer
|
|
+25K
|
$3.56
|
+$87.34K
|
|
SEC
|
Hart Jayne B.
|
Executive VP Human Resources
|
|
-6.1K
|
$12.44
|
-$75.88K
|
|
SEC
|
Jackson Benjamin
|
E.V.P., General Counsel
|
|
-3.8K
|
$12.44
|
-$46.71K
|
|
SEC
|
Lambert Nicole
|
President, MGL
|
|
-4.2K
|
$12.44
|
-$52.30K
|
|
SEC
|
LANCHBURY JERRY S
|
Chief Scientific Officer
|
|
+19K
|
$3.61
|
+$70.09K
|
|
SEC
|
Parkinson Paul
|
EVP Strategy and Innovation
|
|
-7.8K
|
$12.44
|
-$96.57K
|
|
SEC
|
Riggsbee Richard Bryan
|
Chief Financial Officer
|
|
+25K
|
$3.56
|
+$87.34K
|
|
SEC
|
Verratti Mark
|
President Assurex Health Inc.
|
|
+25K
|
$2.48
|
+$61.08K
|
|
SEC
|
Ford Alexander
|
Chief Operating Officer
|
|
-2.8K
|
$13.78
|
-$38.64K
|
|
SEC
|
Lambert Nicole
|
President, MGL
|
|
-4.4K
|
$19.73
|
-$85.90K
|
|
SEC
|
Ford Alexander
|
President, MWH
|
|
-7.3K
|
$30.00
|
-$218.19K
|
|
SEC
|
Ford Alexander
|
President, MWH
|
|
+1.3K
|
$15.98
|
+$20.89K
|
|
SEC
|
GILBERT WALTER PHD
|
N/A
|
|
+5.9K
|
$25.60
|
+$150.02K
|
|
SEC
|
HENDERSON JOHN T
|
N/A
|
|
+7K
|
$23.46
|
+$164.22K
|
|
SEC
|
Riggsbee Richard Bryan
|
Chief Financial Officer
|
|
-2.5K
|
$30.01
|
-$75.03K
|
|
SEC
|
Capone Mark Christopher
|
President & C.E.O.
|
|
-27K
|
$28.63
|
-$773.64K
|
|
SEC
|
Ford Alexander
|
President, MWH
|
|
-8.5K
|
$28.63
|
-$242.87K
|
|
SEC
|
Jackson Benjamin
|
E.V.P., General Counsel
|
|
-833
|
$28.63
|
-$23.85K
|
|
SEC
|
King Gary A.
|
Exec. VP International Ops
|
|
-7.2K
|
$28.63
|
-$204.79K
|
|
SEC
|
Lambert Nicole
|
President, MGL
|
|
-1.2K
|
$28.63
|
-$33.84K
|
|
SEC
|
LANCHBURY JERRY S
|
Chief Scientific Officer
|
|
-11K
|
$28.63
|
-$306.37K
|
|
SEC
|
McDade Ralph L
|
President Myriad RBM, Inc.
|
|
-5.3K
|
$28.63
|
-$152.11K
|
|
SEC
|
Riggsbee Richard Bryan
|
Chief Financial Officer
|
|
-12K
|
$28.63
|
-$341.90K
|
|
SEC
|
Tobin Bernard
|
President Crescendo BioScience
|
|
-11K
|
$28.63
|
-$317.99K
|
|
SEC
|
Verratti Mark
|
President Assurex Health Inc.
|
|
-725
|
$28.63
|
-$20.76K
|
|
SEC
|
Capone Mark Christopher
|
President & C.E.O.
|
|
+108K
|
$5.78
|
+$626.58K
|
|
SEC
|
Ford Alexander
|
President, MWH
|
|
+36K
|
$6.00
|
+$213.48K
|
|
SEC
|
Jackson Benjamin
|
E.V.P., General Counsel
|
|
+39K
|
$0.60
|
+$23.51K
|
|
SEC
|
King Gary A.
|
Exec. VP International Ops
|
|
+21K
|
$5.68
|
+$117.46K
|
|
SEC
|
Lambert Nicole
|
President, MGL
|
|
+39K
|
$0.92
|
+$35.63K
|
|
SEC
|
LANCHBURY JERRY S
|
Chief Scientific Officer
|
|
+28K
|
$6.12
|
+$172.84K
|
|
SEC
|
McDade Ralph L
|
President Myriad RBM, Inc.
|
|
+24K
|
$4.71
|
+$114.88K
|
|
SEC
|
Riggsbee Richard Bryan
|
Chief Financial Officer
|
|
+36K
|
$6.00
|
+$213.48K
|
|
SEC
|
Tobin Bernard
|
President Crescendo BioScience
|
|
+26K
|
$6.28
|
+$161.41K
|
|
SEC
|
Verratti Mark
|
President Assurex Health Inc.
|
|
-5.8K
|
$29.93
|
-$173.41K
|
|
SEC
|
Capone Mark Christopher
|
President & C.E.O.
|
|
-137K
|
$44.00
|
-$6.03M
|
|
SEC
|
King Gary A.
|
Exec. VP International Ops
|
|
-60K
|
$43.49
|
-$2.61M
|
|
SEC
|
Riggsbee Richard Bryan
|
Chief Financial Officer
|
|
-25K
|
$41.50
|
-$1.04M
|
|
SEC
|
Tobin Bernard
|
President Crescendo BioScience
|
|
-12K
|
$40.00
|
-$468.48K
|
|
SEC
|
McDade Ralph L
|
President Myriad RBM, Inc.
|
|
-2K
|
$31.00
|
-$61.23K
|
|
SEC
|
Tobin Bernard
|
President Crescendo BioScience
|
|
-3.7K
|
$29.00
|
-$108.29K
|
|
SEC
|
Riggsbee Richard Bryan
|
Chief Financial Officer
|
|
-3.3K
|
$44.45
|
-$147.89K
|
|
SEC
|
Capone Mark Christopher
|
President & C.E.O.
|
|
-27K
|
$46.00
|
-$1.24M
|
|
SEC
|
Ford Alexander
|
President, MGL
|
|
-8.5K
|
$46.00
|
-$390.22K
|
|
SEC
|
King Gary A.
|
Exec. VP International Ops
|
|
-7.2K
|
$46.00
|
-$329.04K
|
|
SEC
|
LANCHBURY JERRY S
|
Chief Scientific Officer
|
|
-11K
|
$46.00
|
-$492.25K
|
|
SEC
|
MARSH RICHARD M
|
E.V.P., General Counsel
|
|
-11K
|
$46.00
|
-$484.93K
|
|
SEC
|
McDade Ralph L
|
President Myriad RBM, Inc.
|
|
-5.3K
|
$46.00
|
-$244.40K
|
|
SEC
|
Riggsbee Richard Bryan
|
Chief Financial Officer
|
|
-12K
|
$46.00
|
-$549.33K
|
|
SEC
|
Sanders Walter Lloyd
|
President Myriad Oncology
|
|
-1.3K
|
$46.00
|
-$57.87K
|
|
SEC
|
Tobin Bernard
|
President Crescendo BioScience
|
|
-11K
|
$46.00
|
-$510.92K
|
|
SEC
|
Verratti Mark
|
President Assurex Health Inc.
|
|
-725
|
$46.00
|
-$33.35K
|
|
SEC
|
Capone Mark Christopher
|
President & C.E.O.
|
|
-18K
|
$46.65
|
-$853.46K
|
|
SEC
|
Ford Alexander
|
President, MGL
|
|
-6.7K
|
$46.65
|
-$310.36K
|
|
SEC
|
King Gary A.
|
Exec. VP International Ops
|
|
-3.3K
|
$46.65
|
-$155.20K
|
|
SEC
|
LANCHBURY JERRY S
|
Chief Scientific Officer
|
|
-5.5K
|
$46.65
|
-$258.63K
|
|
SEC
|
MARSH RICHARD M
|
E.V.P., General Counsel
|
|
-5.5K
|
$46.65
|
-$258.63K
|
|
SEC
|
McDade Ralph L
|
President Myriad RBM, Inc.
|
|
-3K
|
$46.65
|
-$137.71K
|
|
SEC
|
Riggsbee Richard Bryan
|
Chief Financial Officer
|
|
-6.7K
|
$46.65
|
-$310.36K
|
|
SEC
|
Sanders Walter Lloyd
|
President Myriad Oncology
|
|
-1.7K
|
$46.65
|
-$77.63K
|
|
SEC
|
Tobin Bernard
|
President Crescendo BioScience
|
|
-5K
|
$46.65
|
-$231.29K
|
|
SEC
|
Verratti Mark
|
President Assurex Health Inc.
|
|
-2.9K
|
$46.65
|
-$135.15K
|
|
SEC
|
Capone Mark Christopher
|
President & C.E.O.
|
|
-11K
|
$46.35
|
-$511.01K
|
|
SEC
|
Ford Alexander
|
President, MGL
|
|
-1.8K
|
$46.35
|
-$84.82K
|
|
SEC
|
King Gary A.
|
Exec. VP International Ops
|
|
-5.1K
|
$46.35
|
-$236.43K
|
|
SEC
|
LANCHBURY JERRY S
|
Chief Scientific Officer
|
|
-6.5K
|
$46.35
|
-$301.97K
|
|
SEC
|
MARSH RICHARD M
|
E.V.P., General Counsel
|
|
-6.3K
|
$46.35
|
-$292.65K
|
|
SEC
|
McDade Ralph L
|
President Myriad RBM, Inc.
|
|
-3.1K
|
$46.35
|
-$145.91K
|
|
SEC
|
Sanders Walter Lloyd
|
President Myriad Oncology
|
|
-844
|
$46.35
|
-$39.12K
|
|
SEC
|
MARSH RICHARD M
|
E.V.P., General Counsel
|
|
-7.6K
|
$31.31
|
-$238.68K
|
|
SEC
|
MARSH RICHARD M
|
E.V.P., General Counsel
|
|
+3.8K
|
$34.77
|
+$131.26K
|
|
SEC
|
MARSH RICHARD M
|
E.V.P., General Counsel
|
|
-18K
|
$27.32
|
-$498.84K
|
|
SEC
|
Tobin Bernard
|
President Crescendo BioScience
|
|
-3.6K
|
$34.91
|
-$126.41K
|
|
SEC
|
GILBERT WALTER PHD
|
N/A
|
|
-7.5K
|
$33.19
|
-$248.92K
|
|
SEC
|
DREISMANN HEINRICH
|
N/A
|
|
-6K
|
$33.50
|
-$201.00K
|
|
SEC
|
Ford Alexander
|
President, MGL
|
|
-3K
|
$31.64
|
-$95.90K
|
|
SEC
|
Riggsbee Richard Bryan
|
Chief Financial Officer
|
|
-3.5K
|
$35.84
|
-$126.23K
|
|
SEC
|
Capone Mark Christopher
|
President & C.E.O.
|
|
-29K
|
$36.18
|
-$1.03M
|
|
SEC
|
Ford Alexander
|
President, MGL
|
|
-9K
|
$36.18
|
-$324.90K
|
|
SEC
|
King Gary A.
|
Exec. VP International Ops
|
|
-7.6K
|
$36.18
|
-$273.95K
|
|
SEC
|
LANCHBURY JERRY S
|
Chief Scientific Officer
|
|
-11K
|
$36.18
|
-$409.85K
|
|
SEC
|
MARSH RICHARD M
|
E.V.P., General Counsel
|
|
-11K
|
$36.18
|
-$403.77K
|
|
SEC
|
McDade Ralph L
|
President Myriad RBM, Inc.
|
|
-3.7K
|
$36.18
|
-$133.61K
|
|
SEC
|
Riggsbee Richard Bryan
|
Chief Financial Officer
|
|
-13K
|
$36.18
|
-$457.39K
|
|
SEC
|
Tobin Bernard
|
President Crescendo BioScience
|
|
-12K
|
$36.18
|
-$422.94K
|
|
SEC
|
Verratti Mark
|
President Assurex Health Inc.
|
|
-800
|
$36.18
|
-$28.94K
|
|
SEC
|
Capone Mark Christopher
|
President & C.E.O.
|
|
-12K
|
$33.05
|
-$385.73K
|
|
SEC
|
Ford Alexander
|
President, MGL
|
|
-1.9K
|
$33.05
|
-$64.02K
|
|
SEC
|
King Gary A.
|
Exec. VP International Ops
|
|
-5.4K
|
$33.05
|
-$178.47K
|
|
SEC
|
LANCHBURY JERRY S
|
Chief Scientific Officer
|
|
-6.9K
|
$33.05
|
-$227.95K
|
|
SEC
|
MARSH RICHARD M
|
E.V.P., General Counsel
|
|
-6.7K
|
$33.05
|
-$220.91K
|
|
SEC
|
McDade Ralph L
|
President Myriad RBM, Inc.
|
|
-2.2K
|
$33.05
|
-$72.31K
|
|
SEC
|
HENDERSON JOHN T
|
N/A
|
|
-30K
|
$30.30
|
-$909.00K
|
|
SEC
|
HENDERSON JOHN T
|
N/A
|
|
+6K
|
$18.66
|
+$111.96K
|
|
SEC
|
Tobin Bernard
|
President Crescendo BioScience
|
|
-2.6K
|
$16.93
|
-$44.54K
|
|
SEC
|
Capone Mark Christopher
|
President & C.E.O.
|
|
+10K
|
$21.24
|
+$212.40K
|
|
SEC
|
McDade Ralph L
|
President Myriad RBM, Inc.
|
|
+1K
|
$21.49
|
+$21.49K
|
|
SEC
|
Ford Alexander
|
President, MGL
|
|
-19K
|
$30.87
|
-$575.32K
|
|
SEC
|
King Gary A.
|
Exec. VP International Ops
|
|
-15K
|
$39.03
|
-$585.45K
|
|
SEC
|
King Gary A.
|
Exec. VP International Ops
|
|
-15K
|
$38.12
|
-$571.80K
|
|
SEC
|
GILBERT WALTER PHD
|
N/A
|
|
-5K
|
$42.23
|
-$211.15K
|
|
SEC
|
Phanstiel S. Louise
|
N/A
|
|
-5K
|
$44.00
|
-$220.00K
|
|
SEC
|
DREISMANN HEINRICH
|
N/A
|
|
-60K
|
$44.44
|
-$2.67M
|
|
SEC
|
MARSH RICHARD M
|
E.V.P., General Counsel
|
|
-35K
|
$44.50
|
-$1.56M
|
|
SEC
|
King Gary A.
|
Exec. VP International Ops
|
|
-10K
|
$42.82
|
-$428.20K
|
|
SEC
|
LANCHBURY JERRY S
|
Chief Scientific Officer
|
|
-51K
|
$41.86
|
-$2.13M
|
|
SEC
|
LANCHBURY JERRY S
|
Chief Scientific Officer
|
|
-25K
|
$41.80
|
-$1.04M
|
|
SEC
|
LANCHBURY JERRY S
|
Chief Scientific Officer
|
|
-60K
|
$39.89
|
-$2.40M
|
|
SEC
|
MARSH RICHARD M
|
E.V.P., General Counsel
|
|
-35K
|
$41.25
|
-$1.44M
|
|
SEC
|
King Gary A.
|
Exec. VP International Ops
|
|
-15K
|
$39.41
|
-$573.89K
|
|
SEC
|
King Gary A.
|
Exec. VP International Ops
|
|
-25K
|
$39.41
|
-$1.00M
|
|
SEC
|
King Gary A.
|
Exec. VP International Ops
|
|
-15K
|
$38.23
|
-$573.45K
|
|
SEC
|
King Gary A.
|
Exec. VP International Ops
|
|
-30K
|
$35.73
|
-$1.07M
|
|
SEC
|
King Gary A.
|
Exec. VP International Ops
|
|
-6.6K
|
$39.95
|
-$262.39K
|
|
SEC
|
Evans James S
|
Chief Financial Officer
|
|
-22K
|
$38.99
|
-$851.93K
|
|
SEC
|
Evans James S
|
Chief Financial Officer
|
|
-8.8K
|
$37.98
|
-$333.84K
|
|
SEC
|
Evans James S
|
Chief Financial Officer
|
|
-110K
|
$37.89
|
-$4.19M
|
|
SEC
|
LANCHBURY JERRY S
|
Chief Scientific Officer
|
|
-20K
|
$39.85
|
-$797.00K
|
|
SEC
|
MELDRUM PETER D
|
President & C.E.O.
|
|
-24K
|
$39.50
|
-$948.00K
|
|
SEC
|
Rogers Ronald S.
|
Exec VP Corp Communications
|
|
-13K
|
$36.01
|
-$450.13K
|
|
SEC
|
MARSH RICHARD M
|
E.V.P., General Counsel
|
|
-30K
|
$41.80
|
-$1.25M
|
|
SEC
|
MARSH RICHARD M
|
E.V.P., General Counsel
|
|
-32K
|
$39.80
|
-$1.25M
|
|
SEC
|
MARSH RICHARD M
|
E.V.P., General Counsel
|
|
-28K
|
$39.80
|
-$1.13M
|
|
SEC
|
Hart Jayne B.
|
Executive VP Human Resources
|
|
-79K
|
$40.90
|
-$3.23M
|
|
SEC
|
Evans James S
|
Chief Financial Officer
|
|
-80K
|
$40.00
|
-$3.20M
|
|
SEC
|
LANCHBURY JERRY S
|
Chief Scientific Officer
|
|
-93K
|
$39.70
|
-$3.69M
|
|
SEC
|
MELDRUM PETER D
|
President & C.E.O.
|
|
-55K
|
$39.57
|
-$2.18M
|
|
SEC
|
MELDRUM PETER D
|
President & C.E.O.
|
|
-55K
|
$37.00
|
-$2.04M
|
|
SEC
|
MELDRUM PETER D
|
President & C.E.O.
|
|
-55K
|
$35.15
|
-$1.93M
|
|
SEC
|
MARSH RICHARD M
|
E.V.P., General Counsel
|
|
-50K
|
$34.37
|
-$1.72M
|
|
SEC
|
HENDERSON JOHN T
|
N/A
|
|
-20K
|
$37.86
|
-$757.20K
|
|
SEC
|
HENDERSON JOHN T
|
N/A
|
|
-5K
|
$37.59
|
-$187.95K
|
|
SEC
|
GILBERT WALTER PHD
|
N/A
|
|
-30K
|
$37.58
|
-$1.13M
|
|
SEC
|
Capone Mark Christopher
|
President, MGL
|
|
-95K
|
$37.83
|
-$3.60M
|
|
SEC
|
King Gary A.
|
Exec. VP International Ops
|
|
-20K
|
$38.00
|
-$760.00K
|
|
SEC
|
Evans James S
|
Chief Financial Officer
|
|
-30K
|
$36.01
|
-$1.08M
|
|
SEC
|
Harrison Robert Gardner
|
Chief Information Officer
|
|
-18K
|
$36.22
|
-$635.81K
|
|
SEC
|
GILBERT WALTER PHD
|
N/A
|
|
-60K
|
$34.48
|
-$2.07M
|
|
SEC
|
MARSH RICHARD M
|
E.V.P., General Counsel
|
|
-35K
|
$34.71
|
-$1.20M
|
|
SEC
|
DREISMANN HEINRICH
|
N/A
|
|
-30K
|
$35.00
|
-$1.05M
|
|
SEC
|
King Gary A.
|
Exec. VP International Ops
|
|
-25K
|
$34.74
|
-$868.50K
|
|
SEC
|
LANCHBURY JERRY S
|
Chief Scientific Officer
|
|
-34K
|
$34.55
|
-$1.18M
|
|
SEC
|
MARSH RICHARD M
|
E.V.P., General Counsel
|
|
-21K
|
$31.50
|
-$660.24K
|
|
SEC
|
Harrison Robert Gardner
|
Chief Information Officer
|
|
-14K
|
$30.74
|
-$421.35K
|
|
SEC
|
Capone Mark Christopher
|
President, MGL
|
|
-88K
|
$32.07
|
-$2.81M
|
|
SEC
|
Evans James S
|
Chief Financial Officer
|
|
-35K
|
$33.04
|
-$1.16M
|
|
SEC
|
MELDRUM PETER D
|
President & C.E.O.
|
|
-124K
|
$31.10
|
-$3.85M
|
|
SEC
|
MELDRUM PETER D
|
President & C.E.O.
|
|
-32K
|
$26.50
|
-$842.28K
|
|
SEC
|
Harrison Robert Gardner
|
Chief Information Officer
|
|
-31K
|
$36.17
|
-$1.14M
|
|
SEC
|
Capone Mark Christopher
|
President, MGL
|
|
-80K
|
$33.23
|
-$2.66M
|
|
SEC
|
MELDRUM PETER D
|
President & C.E.O.
|
|
-15K
|
$34.00
|
-$510.00K
|
|
SEC
|
DREISMANN HEINRICH
|
N/A
|
|
-30K
|
$31.16
|
-$934.80K
|
|
SEC
|
MARSH RICHARD M
|
E.V.P., General Counsel
|
|
-48K
|
$33.00
|
-$1.59M
|
|
SEC
|
MELDRUM PETER D
|
President & C.E.O.
|
|
-76K
|
$31.99
|
-$2.43M
|
|
SEC
|
HENDERSON JOHN T
|
N/A
|
|
-40K
|
$27.65
|
-$1.11M
|
|
SEC
|
LANCHBURY JERRY S
|
Chief Scientific Officer
|
|
-20K
|
$27.18
|
-$543.60K
|
|
SEC
|
Harrison Robert Gardner
|
Chief Information Officer
|
|
-3.5K
|
$29.95
|
-$104.23K
|
|
SEC
|
LANGER DENNIS
|
N/A
|
|
-70K
|
$29.88
|
-$2.09M
|
|
SEC
|
MELDRUM PETER D
|
President & C.E.O.
|
|
-20K
|
$30.59
|
-$611.80K
|
|
SEC
|
Capone Mark Christopher
|
President, MGL
|
|
-62K
|
$29.91
|
-$1.86M
|
|
SEC
|
MELDRUM PETER D
|
President & C.E.O.
|
|
-50K
|
$29.81
|
-$1.49M
|
|
SEC
|
MELDRUM PETER D
|
President & C.E.O.
|
|
-18K
|
$29.61
|
-$539.43K
|
|
SEC
|
Capone Mark Christopher
|
President, MGL
|
|
-27K
|
$28.75
|
-$776.25K
|
|
SEC
|
Harrison Robert Gardner
|
Chief Information Officer
|
|
-38K
|
$30.05
|
-$1.16M
|
|
SEC
|
LANCHBURY JERRY S
|
Chief Scientific Officer
|
|
-30K
|
$30.42
|
-$909.01K
|
|
SEC
|
MARSH RICHARD M
|
E.V.P., General Counsel
|
|
-63K
|
$29.05
|
-$1.83M
|
|
SEC
|
LANCHBURY JERRY S
|
Chief Scientific Officer
|
|
-3.9K
|
$28.50
|
-$111.15K
|
|
SEC
|
Evans James S
|
Chief Financial Officer
|
|
-35K
|
$28.06
|
-$982.10K
|
|
SEC
|
Evans James S
|
Chief Financial Officer
|
|
-26K
|
$26.99
|
-$708.49K
|
|
SEC
|
LANCHBURY JERRY S
|
Chief Scientific Officer
|
|
-5K
|
$28.00
|
-$140.00K
|
|
SEC
|
MELDRUM PETER D
|
President & C.E.O.
|
|
-20K
|
$27.60
|
-$552.00K
|
|
SEC
|
Evans James S
|
Chief Financial Officer
|
|
-5.5K
|
$27.10
|
-$148.89K
|
|
SEC
|
Evans James S
|
Chief Financial Officer
|
|
-25K
|
$27.01
|
-$661.91K
|
|
SEC
|
MARSH RICHARD M
|
E.V.P., General Counsel
|
|
-19K
|
$27.00
|
-$521.10K
|
|
SEC
|
MELDRUM PETER D
|
President & C.E.O.
|
|
-20K
|
$26.92
|
-$538.40K
|
|
SEC
|
Capone Mark Christopher
|
President, MGL
|
|
-20K
|
$27.00
|
-$534.74K
|
|
SEC
|
GILBERT WALTER PHD
|
N/A
|
|
-60K
|
$25.99
|
-$1.56M
|
|
SEC
|
Evans James S
|
Chief Financial Officer
|
|
-15K
|
$26.01
|
-$400.55K
|
|
SEC
|
MELDRUM PETER D
|
President & C.E.O.
|
|
-1.5K
|
$25.90
|
-$38.28K
|
|
SEC
|
MELDRUM PETER D
|
President & C.E.O.
|
|
-29K
|
$25.72
|
-$733.59K
|
|
SEC
|
Capone Mark Christopher
|
President, MGL
|
|
-4.3K
|
$27.00
|
-$114.94K
|
|
SEC
|
MARSH RICHARD M
|
E.V.P., General Counsel
|
|
-700
|
$27.00
|
-$18.90K
|
|
SEC
|
MELDRUM PETER D
|
President & C.E.O.
|
|
-39K
|
$26.27
|
-$1.03M
|
|
SEC
|
MARSH RICHARD M
|
E.V.P., General Counsel
|
|
-20K
|
$26.03
|
-$520.60K
|
|
SEC
|
MELDRUM PETER D
|
President & C.E.O.
|
|
-40K
|
$25.42
|
-$1.02M
|
|
SEC
|
LANCHBURY JERRY S
|
Chief Scientific Officer
|
|
-30K
|
$25.00
|
-$750.00K
|
|
SEC
|
Evans James S
|
Chief Financial Officer
|
|
-4.6K
|
$25.01
|
-$115.05K
|
|
SEC
|
Harrison Robert Gardner
|
Chief Information Officer
|
|
-36K
|
$24.99
|
-$899.64K
|
|
SEC
|
MELDRUM PETER D
|
President & C.E.O.
|
|
-10K
|
$24.94
|
-$249.40K
|
|
SEC
|
MELDRUM PETER D
|
President & C.E.O.
|
|
-17K
|
$24.51
|
-$423.92K
|
|
SEC
|
MARSH RICHARD M
|
E.V.P., General Counsel
|
|
-53K
|
$23.99
|
-$1.27M
|
|
SEC
|
MELDRUM PETER D
|
President & C.E.O.
|
|
-30K
|
$23.78
|
-$720.44K
|
|
SEC
|
Harrison Robert Gardner
|
Chief Information Officer
|
|
-2.2K
|
$23.40
|
-$51.57K
|
|
SEC
|
MARSH RICHARD M
|
E.V.P., General Counsel
|
|
-13K
|
$24.02
|
-$304.72K
|
|
SEC
|
MELDRUM PETER D
|
President & C.E.O.
|
|
-6.5K
|
$24.00
|
-$156.00K
|
|
SEC
|
Evans James S
|
Chief Financial Officer
|
|
-8.8K
|
$23.98
|
-$211.02K
|
|
SEC
|
MELDRUM PETER D
|
President & C.E.O.
|
|
-53K
|
$23.97
|
-$1.28M
|
|
SEC
|
LANCHBURY JERRY S
|
Chief Scientific Officer
|
|
-22K
|
$24.05
|
-$524.39K
|
|
SEC
|
MELDRUM PETER D
|
President & C.E.O.
|
|
-30K
|
$23.95
|
-$723.29K
|
|
SEC
|
MELDRUM PETER D
|
President & C.E.O.
|
|
-15K
|
$23.04
|
-$345.60K
|
|
SEC
|
MELDRUM PETER D
|
President & C.E.O.
|
|
-20K
|
$23.99
|
-$479.80K
|
|
SEC
|
MELDRUM PETER D
|
President & C.E.O.
|
|
-20K
|
$25.00
|
-$500.00K
|
|
SEC
|
Evans James S
|
Chief Financial Officer
|
|
-5K
|
$24.65
|
-$123.25K
|
|
SEC
|
LANCHBURY JERRY S
|
Chief Scientific Officer
|
|
-44K
|
$25.00
|
-$1.11M
|
|
SEC
|
MELDRUM PETER D
|
President & C.E.O.
|
|
-20K
|
$24.67
|
-$493.40K
|
|
SEC
|
Evans James S
|
Chief Financial Officer
|
|
-5K
|
$24.50
|
-$122.50K
|
|
SEC
|
Harrison Robert Gardner
|
Chief Information Officer
|
|
-20K
|
$23.08
|
-$461.60K
|
|
SEC
|
MARSH RICHARD M
|
E.V.P., General Counsel
|
|
-69K
|
$23.21
|
-$1.61M
|
|
SEC
|
LANCHBURY JERRY S
|
Chief Scientific Officer
|
|
-5.3K
|
$22.75
|
-$120.58K
|
|
SEC
|
LANCHBURY JERRY S
|
Chief Scientific Officer
|
|
-4.7K
|
$22.00
|
-$103.40K
|
|
SEC
|
BEST LAWRENCE C
|
N/A
|
|
-90K
|
$21.54
|
-$1.94M
|
|
SEC
|
Evans James S
|
Chief Financial Officer
|
|
-8.4K
|
$23.95
|
-$201.18K
|
|
SEC
|
MELDRUM PETER D
|
President & C.E.O.
|
|
-31K
|
$22.30
|
-$685.81K
|
|
SEC
|
MELDRUM PETER D
|
President & C.E.O.
|
|
-46K
|
$22.97
|
-$1.06M
|
|
SEC
|
WILSON LINDA S
|
N/A
|
|
-31K
|
$26.90
|
-$820.45K
|
|
SEC
|
LANCHBURY JERRY S
|
Executive V.P. - Research
|
|
-26K
|
$26.01
|
-$687.39K
|
|
SEC
|
SKOLNICK MARK H
|
Chief Scientific Officer
|
|
-192K
|
$25.44
|
-$4.88M
|
|
SEC
|
Harrison Robert Gardner
|
Chief Information Officer
|
|
-13K
|
$31.11
|
-$410.53K
|
|
SEC
|
CRITCHFIELD GREGORY C
|
President Myriad Genetic Labs
|
|
-47K
|
$30.75
|
-$1.44M
|
|
SEC
|
HOBDEN ADRIAN N
|
Pres. Myriad Pharmaceuticals
|
|
-40K
|
$34.01
|
-$1.36M
|
|
SEC
|
HENDERSON JOHN T
|
N/A
|
|
+300
|
$32.73
|
+$9.82K
|
|
SEC
|
SKOLNICK MARK H
|
Chief Scientific Officer
|
|
-22K
|
$32.36
|
-$711.66K
|
|
SEC
|
Capone Mark Christopher
|
Chief Operating Officer, MGL
|
|
-36K
|
$43.07
|
-$1.55M
|
|
SEC
|
Laslie W Wayne
|
Chief Operating Officer, MPI
|
|
-24K
|
$44.96
|
-$1.08M
|
|
SEC
|
LANCHBURY JERRY S
|
Executive V.P. - Research
|
|
-20K
|
$46.74
|
-$934.80K
|
|
SEC
|
SKOLNICK MARK H
|
Chief Scientific Officer
|
|
-2K
|
$79.00
|
-$158.00K
|
|
SEC
|
SKOLNICK MARK H
|
Chief Scientific Officer
|
|
-9K
|
$80.36
|
-$723.24K
|
|
SEC
|
Capone Mark Christopher
|
Chief Operating Officer, MGL
|
|
-22K
|
$85.40
|
-$1.87M
|
|
SEC
|
HENDERSON JOHN T
|
N/A
|
|
-10K
|
$82.46
|
-$824.60K
|
|
SEC
|
HOBDEN ADRIAN N
|
Pres. Myriad Pharmaceuticals
|
|
-24K
|
$83.60
|
-$2.01M
|
|
SEC
|
LANGER DENNIS
|
N/A
|
|
-15K
|
$82.72
|
-$1.24M
|
|
SEC
|
MELDRUM PETER D
|
President & C.E.O.
|
|
-25K
|
$83.09
|
-$2.08M
|
|
SEC
|
MARSH RICHARD M
|
V.P., General Counsel
|
|
-11K
|
$85.00
|
-$935.00K
|
|
SEC
|
CRITCHFIELD GREGORY C
|
President Myriad Genetic Labs
|
|
-20K
|
$84.50
|
-$1.69M
|
|
SEC
|
Evans James S
|
Chief Financial Officer
|
|
-11K
|
$80.01
|
-$877.23K
|
|
SEC
|
Harrison Robert Gardner
|
Chief Information Officer
|
|
-4K
|
$82.50
|
-$330.00K
|
|
SEC
|
LANCHBURY JERRY S
|
Executive V.P. - Research
|
|
-10K
|
$82.00
|
-$820.00K
|
|
SEC
|
LANCHBURY JERRY S
|
Executive V.P. - Research
|
|
-10K
|
$67.00
|
-$670.00K
|
|
SEC
|
WILSON LINDA S
|
N/A
|
|
-16K
|
$63.91
|
-$1.02M
|
|
SEC
|
SKOLNICK MARK H
|
Chief Scientific Officer
|
|
-10K
|
$71.15
|
-$711.50K
|
|
SEC
|
Laslie W Wayne
|
Chief Operating Officer, MPI
|
|
-12K
|
$70.00
|
-$840.00K
|
|
SEC
|
MELDRUM PETER D
|
President & C.E.O.
|
|
-10K
|
$70.37
|
-$703.70K
|
|
SEC
|
Evans James S
|
Chief Financial Officer
|
|
-6.7K
|
$69.00
|
-$460.16K
|
|
SEC
|
HOBDEN ADRIAN N
|
Pres. Myriad Pharmaceuticals
|
|
-15K
|
$68.54
|
-$1.03M
|
|
SEC
|
HOBDEN ADRIAN N
|
Pres. Myriad Pharmaceuticals
|
|
-992
|
$66.00
|
-$65.47K
|
|
SEC
|
WILSON LINDA S
|
N/A
|
|
-13K
|
$65.81
|
-$822.63K
|
|
SEC
|
CRITCHFIELD GREGORY C
|
President Myriad Genetic Labs
|
|
-32K
|
$66.08
|
-$2.14M
|
|
SEC
|
HOBDEN ADRIAN N
|
Pres. Myriad Pharmaceuticals
|
|
-500
|
$66.49
|
-$33.25K
|
|
SEC
|
SKOLNICK MARK H
|
Chief Scientific Officer
|
|
-20K
|
$66.00
|
-$1.29M
|
|
SEC
|
HOCKETT WILLIAM A III
|
V. P. of Corp Communications
|
|
-28K
|
$64.04
|
-$1.82M
|
|
SEC
|
GILBERT WALTER PHD
|
N/A
|
|
-10K
|
$63.31
|
-$633.10K
|
|
SEC
|
LANGER DENNIS
|
N/A
|
|
-10K
|
$64.78
|
-$647.80K
|
|
SEC
|
LANCHBURY JERRY S
|
Executive V.P. - Research
|
|
-20K
|
$67.07
|
-$1.34M
|
|
SEC
|
SKOLNICK MARK H
|
Chief Scientific Officer
|
|
-500
|
$68.51
|
-$34.26K
|
|
SEC
|
MARSH RICHARD M
|
V.P., General Counsel
|
|
-11K
|
$68.26
|
-$764.38K
|
|
SEC
|
MELDRUM PETER D
|
President & C.E.O.
|
|
-16K
|
$68.07
|
-$1.09M
|
|
SEC
|
Harrison Robert Gardner
|
Chief Information Officer
|
|
-4.1K
|
$65.90
|
-$269.20K
|
|
SEC
|
HOBDEN ADRIAN N
|
Pres. Myriad Pharmaceuticals
|
|
-27K
|
$65.03
|
-$1.79M
|
|
SEC
|
SKOLNICK MARK H
|
Chief Scientific Officer
|
|
-20K
|
$34.90
|
-$698.00K
|
|
SEC
|
SKOLNICK MARK H
|
Chief Scientific Officer
|
|
-25K
|
$38.92
|
-$973.00K
|
|
SEC
|
LANGER DENNIS
|
N/A
|
|
-30K
|
$47.57
|
-$1.43M
|
|
SEC
|
HOCKETT WILLIAM A III
|
V. P. of Corp Communications
|
|
-2.7K
|
$51.00
|
-$137.29K
|
|
SEC
|
SKOLNICK MARK H
|
Chief Scientific Officer
|
|
-27K
|
$50.44
|
-$1.36M
|
|
SEC
|
Laslie W Wayne
|
Chief Operating Officer, MPI
|
|
-1.1K
|
$48.30
|
-$54.19K
|
|
SEC
|
WILSON LINDA S
|
N/A
|
|
-25K
|
$48.17
|
-$1.20M
|
|
SEC
|
GILBERT WALTER PHD
|
N/A
|
|
-35K
|
$52.92
|
-$1.85M
|
|
SEC
|
Evans James S
|
V.P. Finance
|
|
-6.6K
|
$54.98
|
-$360.39K
|
|
SEC
|
HOCKETT WILLIAM A III
|
V. P. of Corp Communications
|
|
-4.9K
|
$55.67
|
-$272.00K
|
|
SEC
|
MELDRUM PETER D
|
President & C.E.O.
|
|
-20K
|
$55.31
|
-$1.11M
|
|
SEC
|
MOYES JAY M
|
Chief Financial Officer
|
|
-40K
|
$54.75
|
-$2.16M
|
|
SEC
|
Laslie W Wayne
|
Chief Operating Officer, MPI
|
|
-10K
|
$57.26
|
-$572.60K
|
|
SEC
|
LANCHBURY JERRY S
|
Executive V.P. - Research
|
|
-10K
|
$79.29
|
-$792.90K
|
|
SEC
|
LANCHBURY JERRY S
|
Executive V.P. - Research
|
|
-10K
|
$52.00
|
-$521.87K
|
|
SEC
|
CRITCHFIELD GREGORY C
|
President Myriad Genetic Labs
|
|
-28K
|
$50.00
|
-$1.40M
|
|
SEC
|
MARSH RICHARD M
|
V.P., General Counsel
|
|
-13K
|
$50.00
|
-$625.00K
|
|
SEC
|
HOBDEN ADRIAN N
|
Pres. Myriad Pharmaceuticals
|
|
-20K
|
$50.00
|
-$1.00M
|
|
SEC
|
MELDRUM PETER D
|
President & C.E.O.
|
|
-11K
|
$47.04
|
-$529.76K
|
|
SEC
|
Evans James S
|
V.P. Finance
|
|
-3.9K
|
$47.19
|
-$184.70K
|
|
SEC
|
MOYES JAY M
|
Chief Financial Officer
|
|
-80K
|
$47.24
|
-$3.79M
|
|
SEC
|
MELDRUM PETER D
|
President & C.E.O.
|
|
-10K
|
$47.18
|
-$471.80K
|
|
SEC
|
LANCHBURY JERRY S
|
Executive V.P. - Research
|
|
-25K
|
$44.04
|
-$1.10M
|
|
SEC
|
Capone Mark Christopher
|
Chief Operating Officer, MGL
|
|
-4.8K
|
$43.01
|
-$205.29K
|
|
SEC
|
Laslie W Wayne
|
Chief Operating Officer, MPI
|
|
-9K
|
$40.25
|
-$362.25K
|
|
SEC
|
MARSH RICHARD M
|
V.P., General Counsel
|
|
-579
|
$40.00
|
-$23.16K
|
|
SEC
|
MARSH RICHARD M
|
V.P., General Counsel
|
|
-5.6K
|
$40.00
|
-$223.24K
|
|
SEC
|
MARSH RICHARD M
|
V.P., General Counsel
|
|
-6K
|
$37.78
|
-$226.68K
|
|
SEC
|
MOYES JAY M
|
Chief Financial Officer
|
|
-1.5K
|
$37.73
|
-$56.59K
|
|
SEC
|
SKOLNICK MARK H
|
Chief Scientific Officer
|
|
-30K
|
$38.29
|
-$1.15M
|
|
SEC
|
HOBDEN ADRIAN N
|
Pres. Myriad Pharmaceuticals
|
|
-10K
|
$40.00
|
-$400.00K
|
|
SEC
|
GILBERT WALTER PHD
|
N/A
|
|
-30K
|
$38.05
|
-$1.14M
|
|
SEC
|
SKOLNICK MARK H
|
Chief Scientific Officer
|
|
-30K
|
$38.06
|
-$1.14M
|
|
SEC
|
MELDRUM PETER D
|
President & C.E.O.
|
|
-20K
|
$39.38
|
-$787.60K
|
|
SEC
|
HOCKETT WILLIAM A III
|
V. P. of Corp Communications
|
|
-84K
|
$39.74
|
-$3.34M
|
|
SEC
|
MELDRUM PETER D
|
President & C.E.O.
|
|
-10K
|
$38.00
|
-$380.00K
|
|
SEC
|
LANCHBURY JERRY S
|
Executive V.P. - Research
|
|
-8.8K
|
$37.00
|
-$323.75K
|
|
SEC
|
MARSH RICHARD M
|
V.P., General Counsel
|
|
-4K
|
$37.50
|
-$149.66K
|
|
SEC
|
MARSH RICHARD M
|
V.P., General Counsel
|
|
-5K
|
$36.08
|
-$180.40K
|
|
SEC
|
HOCKETT WILLIAM A III
|
V. P. of Corp Communications
|
|
-17K
|
$33.28
|
-$556.61K
|
|
SEC
|
SKOLNICK MARK H
|
Chief Scientific Officer
|
|
-5K
|
$33.81
|
-$169.05K
|
|
SEC
|
Evans James S
|
Vice President Finance
|
|
-5.6K
|
$37.00
|
-$208.16K
|
|
SEC
|
SIMON S GEORGE
|
V.P. Business Development
|
|
-5K
|
$35.09
|
-$175.45K
|
|
SEC
|
MELDRUM PETER D
|
President & C.E.O.
|
|
-10K
|
$35.00
|
-$350.00K
|
|
SEC
|
SIMON S GEORGE
|
V.P. Business Development
|
|
-5K
|
$35.00
|
-$175.00K
|
|
SEC
|
LANCHBURY JERRY S
|
Executive V.P. - Research
|
|
-5K
|
$34.00
|
-$170.00K
|
|
SEC
|
MELDRUM PETER D
|
President & C.E.O.
|
|
-10K
|
$33.00
|
-$330.00K
|
|
SEC
|
MOYES JAY M
|
Chief Financial Officer
|
|
-8.2K
|
$32.50
|
-$265.07K
|
|
SEC
|
HOBDEN ADRIAN N
|
Pres. Myriad Pharmaceuticals
|
|
-5K
|
$32.00
|
-$160.00K
|
|
SEC
|
HOCKETT WILLIAM A III
|
V. P. of Corp Communications
|
|
-5K
|
$32.00
|
-$160.00K
|
|
SEC
|
MELDRUM PETER D
|
President & C.E.O.
|
|
-20K
|
$30.90
|
-$618.00K
|
|
SEC
|
MOYES JAY M
|
Chief Financial Officer
|
|
-8.2K
|
$30.00
|
-$244.68K
|
|
SEC
|
LANCHBURY JERRY S
|
Executive V.P. - Research
|
|
-4.2K
|
$29.00
|
-$121.10K
|
|
SEC
|
GILBERT WALTER PHD
|
N/A
|
|
-36K
|
$26.99
|
-$970.02K
|
|
SEC
|
LANCHBURY JERRY S
|
Executive V.P. - Research
|
|
-824
|
$29.00
|
-$23.90K
|
|
SEC
|
HOCKETT WILLIAM A III
|
V. P. of Corp Communications
|
|
-8.6K
|
$28.00
|
-$240.46K
|
|
SEC
|
MOYES JAY M
|
Chief Financial Officer
|
|
-5K
|
$27.08
|
-$135.40K
|
|
SEC
|
HAYES ARTHUR HULL JR
|
N/A
|
|
-15K
|
$25.13
|
-$376.95K
|
|
SEC
|
SKOLNICK MARK H
|
Chief Scientific Officer
|
|
-27K
|
$24.93
|
-$673.11K
|
|
SEC
|
SKOLNICK MARK H
|
Chief Scientific Officer
|
|
-21K
|
$28.00
|
-$600.21K
|
|
SEC
|
SIMON S GEORGE
|
V.P. Business Development
|
|
-10K
|
$28.02
|
-$280.20K
|
|
SEC
|
MELDRUM PETER D
|
President & C.E.O.
|
|
-8.6K
|
$28.00
|
-$241.58K
|
|
SEC
|
HOBDEN ADRIAN N
|
Pres. Myriad Pharmaceuticals
|
|
-5K
|
$26.01
|
-$130.05K
|
|
SEC
|
CRITCHFIELD GREGORY C
|
President Myriad Genetic Labs
|
|
-36K
|
$24.55
|
-$872.90K
|
|
SEC
|
MARSH RICHARD M
|
V.P., General Counsel
|
|
-10K
|
$27.55
|
-$275.50K
|
|
SEC
|
GILBERT WALTER PHD
|
N/A
|
|
-55K
|
$25.91
|
-$1.43M
|
|
SEC
|
HAYES ARTHUR HULL JR
|
N/A
|
|
-25K
|
$25.73
|
-$643.25K
|
|
SEC
|
MOYES JAY M
|
Chief Financial Officer
|
|
-2.9K
|
$25.21
|
-$73.11K
|
|
SEC
|
MELDRUM PETER D
|
President & C.E.O.
|
|
-10K
|
$25.00
|
-$250.00K
|
|
SEC
|
HOCKETT WILLIAM A III
|
V. P. of Corp Communications
|
|
-3.6K
|
$25.00
|
-$89.70K
|
|
SEC
|
MOYES JAY M
|
Chief Financial Officer
|
|
-13K
|
$25.03
|
-$313.98K
|
|
SEC
|
SIMON S GEORGE
|
V.P. Business Development
|
|
-5K
|
$25.00
|
-$125.00K
|
|
SEC
|
MOYES JAY M
|
Chief Financial Officer
|
|
-2.4K
|
$19.98
|
-$48.91K
|
|
SEC
|
HOBDEN ADRIAN N
|
Pres. Myriad Pharmaceuticals
|
|
-2K
|
$25.00
|
-$50.60K
|
|
SEC
|
SIMON S GEORGE
|
V.P. Business Development
|
|
-2K
|
$25.12
|
-$50.24K
|
|
SEC
|
SIMON S GEORGE
|
V.P. Business Development
|
|
-653
|
$20.00
|
-$13.06K
|
|
SEC
|
HENDERSON JOHN T
|
N/A
|
|
+2K
|
$17.03
|
+$34.06K
|
|